Skip to main content
. Author manuscript; available in PMC: 2021 Nov 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2020 Nov;72(11):1636–1644. doi: 10.1002/acr.24059

Table 3.

Prevalence and association of dermatomyositis (DM) with sunburn and sun exposure in the year prior to diagnosis, by maximum ambient ultraviolet radiation (UV) radiation levels based on residential location at diagnosis*

At or above the median of maximum UV dose
Below the median of maximum UV dose
DM PM/IBM DM vs. PM/IBM DM PM/IBM DM vs. PM/IBM
Effect n (%) n (%) OR (95% CI) P n (%) n (%) OR (95% CI) P Interaction P
Sunburn
 ≥ 2 sunburns 66 (21) 50 (15) 1.52 (0.97–2.38) 0.066 66 (22) 40 (11) 2.05 (1.29–3.27) 0.002 0.468
 1 sunburn 63 (20) 47 (14) 1.62 (1.04–2.54) 0.034 61 (20) 58 (17) 1.25 (0.82–1.92) 0.303 0.350
 No sunburn 184 (59) 246 (72) 1.00 (REF) 175 (58) 252 (72) 1.00 (REF)
Combined sun exposure
 High/Mod-High 35 (13) 40 (14) 1.89 (1.03, 3.48) 0.040 35 (14) 39 (13) 1.34 (0.75, 2.41) 0.329 0.673
 Moderate 151 (58) 140 (50) 1.64 (1.09, 2.47) 0.017 136 (55) 146 (51) 1.13 (0.76, 1.67) 0.546 0.259
 Low/None 75 (29) 98 (35) 1.00 (REF) 78 (31) 104 (36) 1.00 (REF)

Abbreviations: DM, dermatomyositis; PM, polymyositis; IBM, inclusion body myositis; OR, odds ratio; CI, confidence interval; REF, referent group.